HoJin Shin

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Direct Oral Anticoagulants

Clinical Practice

Ankylosing Spondylitis

Systemic Lupus Erythematosus

Top Venues

Annals of internal medicine

Clinical pharmacology and therapeutics

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

HoJin Shin, Shirley V Wang, Dae Hyun Kim, Ethan Alt, Mufaddal Mahesri, Lily G Bessette, Sebastian G Schneeweiss, Mehdi Najafzadeh
Predicting treatment effects of a new-to-market drug in clinical practice based on phase III randomized trial results. Clinical pharmacology and therapeutics (2023)
Mehdi NajafZadeh, HoJin Shin, Sebastian G Schneeweiss, Shirley V Wang, Scott D Solomon, Orly Vardeny, Elisabetta Patorno
High-dose vs. standard-dose influenza vaccine and cardiopulmonary hospitalization or mortality: emulating the INVESTED trial using insurance claims data. Clinical pharmacology and therapeutics (2023)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes. Pharmacoepidemiology and drug safety 31 (5) (2022)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study. Annals of internal medicine 175 (7) (2022)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Annals of internal medicine 175 (12) (2022)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Annals of internal medicine 175 (12) (2022)
HoJin Shin, Sebastian Schneeweiss, Robert J Glynn, Elisabetta Patorno
Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA. Diabetes care 44 (8) (2021)